Identifying Genes for Antiepileptic Drug Response
Author Information
Author(s): Abhay Sharma
Primary Institution: Institute of Genomics and Integrative Biology, Council of Scientific and Industrial Research, Delhi
Hypothesis
Can transcriptomic data-mining help identify potential pharmacogenetic candidate genes in antiepileptic drug therapy?
Conclusion
The analysis supports the candidacy of genes HLA-B and HSPA1A in pharmacogenetics related to antiepileptic drugs.
Supporting Evidence
- The analysis identified 817 up-regulated and 360 down-regulated genes after sodium valproate treatment.
- Both up- and down-regulated genes showed significant enrichment in biological processes related to central nervous system function.
- Two genes, HLA-B and HSPA1A, were found to be common in the up-regulated gene set and associated with AED response.
Takeaway
This study looks at how certain genes might help doctors understand how well epilepsy drugs work for different people.
Methodology
The study analyzed gene expression data from various studies on sodium valproate to identify differentially expressed genes and their biological processes.
Limitations
The small number of genes limited the ability to perform statistical tests for significance.
Statistical Information
P-Value
0.002, 0.012
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website